SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001823239-23-000033
Filing Date
2023-04-06
Accepted
2023-04-06 18:34:44
Documents
4
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_168082046886797.html 3  
1 FORM 3 wf-form3_168082046886797.xml 3 1841
2 DREW BURCH POA exhibit241section16power.htm EX-24 5162
3 DREW BURCH POA IMAGE 1 exhibit241section16power001.jpg GRAPHIC 257271
4 DREW BURCH POA IMAGE 2 exhibit241section16power002.jpg GRAPHIC 68880
  Complete submission text file 0001823239-23-000033.txt   457860
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Issuer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MARAVAI LIFESCIENCES HOLDINGS, INC. 10770 WATERIDGE CIRCLE, SUITE 200 SAN DIEGO CA 92121
Business Address
BURCH ANDREW (Reporting) CIK: 0001970770 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39725 | Film No.: 23807406